FLX Bio is a biotechnology company focused on the discovery and development of novel drugs that will improve and prolong the lives of people with cancer. The company is led by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is supported by several of the nation’s premier life sciences venture capital firms. The company is located in the San Francisco Bay area, in the heart of the world’s largest biotechnology research hub. We offer a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants.
As a member of the Quantitative Biology group, the Senior Scientist will join a dynamic and highly motivated team driving the discovery, characterization and development of immuno-modulatory drugs. The job demands a thorough understanding of small molecule drug discovery from hit identification through clinical candidate selection. As a key member of the group, the successful applicant will lead several scientists in development, optimization and execution of new biochemical and cell-based assays to support our internal drug discovery programs. This position requires working with others within Biology as well as with Medicinal Chemistry, Toxicology and DMPK. The Senior Scientist is expected to contribute at both the applied (at the bench) and strategic levels. A strong candidate will be enthusiastic about supporting the operation of a dynamic laboratory, have great attention to detail and superior organizational skills.
The ideal candidate will have the following qualifications:
- A Ph.D. in a relevant biological science with a minimum of eight years of industry experience.
- A strong record of publications in a relevant scientific discipline.
- Extensive history of cell-based and/or biochemical assay development, optimization and troubleshooting in an automated laboratory environment.
- Deep knowledge of principles of receptor pharmacology and/or enzymology.
- Experience in a pharmaceutical or biopharmaceutical drug discovery environment.
- Strong desire to develop novel therapies that will improve and prolong the lives of people with cancer.
- Be eligible to work in the United States.
The role demands a highly goal-driven approach and the ability to focus on time-sensitive objectives. The candidate should also enjoy operating in an exceptionally dynamic and cooperative environment where every voice matters.
Particular consideration will be given to candidates with a strong working knowledge of immunology, oncology, or other human disease field.
Located in South San Francisco, Calif., and funded by leading investors, including The Column Group (TCG), Kleiner Perkins (KP), Topspin Partners, GV (formerly Google Ventures) and Celgene Corporation, FLX Bio has assembled a leadership team and advisory group with a proven track record of success and team of scientists with substantial knowledge and expertise in drug discovery and translational areas essential to execute on this approach. For more information, please visit www.flxbio.com.
Qualified candidates are encouraged to submit a Resume/CV and cover letter to email@example.com and please refer to job code #SRSCIQB. We are proud to be an equal opportunity employer.